Novel Therapeutic Intervention using Coenzyme Q10 and Insulin Sensitizer on Experimentally- Initiated Diabetic Neuropathy
DOI:
https://doi.org/10.18311/jnr/2022/30085Keywords:
Histopathological Examination, Metformin, Nerve Damage, Nutraceutical, Streptozotocin-nicotinamideAbstract
Diabetes is one of the main disease having many repercussions due to which there is a huge economic burden globally. Therefore, there is a need of good therapeutic intervention by using some nutraceuticals to combat this dreadful disease especially complications such as diabetic neuropathy where patients suffer from severe pain and disability. Therefore, nutraceuticals like coenzyme Q10 and metformin were used in this study to see how they are effective in alleviating the symptoms of diabetic peripheral neuropathy. The animal experiments were conducted to induce neuropathy by using streptozotocin-nicotinamide. Animals were divided into five groups such as control, diabetic control, coenzyme Q10, metformin, and their combination. The nerve function test was conducted by using paw withdrawal response, tail-flick response, and muscular grip strength. Antioxidant parameters were assessed by estimating such MDA, SOD, and GSH. The sciatica nerve was isolated and a histopathological examination was conducted. Neuropathy was assessed in diabetic control animals which showed a substantial decrease in grip strength, increase in the paw withdrawal, and tail-flick response. It was found that there was a rapid improvement in nerve function test when a combination of coenzyme Q10 and metformin was given together as compared to animals given coenzyme Q10 and metformin alone. From this study, it is shown that combination therapy exhibited a better improvement in the nerve function test and control of the free radical generation which ultimately results in nerve damage.Downloads
Metrics
Downloads
Published
How to Cite
Issue
Section
Accepted 2022-06-08
Published 2022-07-30
References
Zangiabadi N, Asadi-Shekaari M, Sheibani V, Jafari M, Shabani M, Asadi AR, et al. Date fruit extract is a neuroprotective agent in diabetic peripheral neuropathy in streptozotocin-induced diabetic rats: A multimodal analysis. Oxid Med Cell Longev. 2011. https://doi.org/10.1155/2011/976948. PMid:22191015. PMCid:PMC3236446 DOI: https://doi.org/10.1155/2011/976948
Gallieni M, Aiello A, Tucci B, Sala V, Brahmochary Mandal SK, Doneda A, et al. The burden of hypertension and kidney disease in Northeast India: The Institute for Indian Mother and Child noncommunicable diseases project. Sci World J. 2014. https://doi.org/10.1155/2014/320869. PMid:24616621. PMCid:PMC3927758 DOI: https://doi.org/10.1155/2014/320869
Belchetz PE, Hammond PJ. Mosby’s color atlas and text of diabetes and endocrinology. Elsevier Health Sciences; 2003.
Houreld NN. Shedding light on a new treatment for diabetic wound healing: A review on phototherapy. Sci World J. 2014. https://doi.org/10.1155/2014/398412. PMid:24511283. PMCid:PMC3913345 DOI: https://doi.org/10.1155/2014/398412
Gilron I, Coderre TJ. Emerging drugs in neuropathic pain. Expert Opin Emerg Drugs. 2007; 12(1);113–26. https://doi.org/10.1517/14728214.12.1.113. PMid:17355217 DOI: https://doi.org/10.1517/14728214.12.1.113
Clark Jr CM, Lee DA. Prevention and treatment of the complications of diabetes mellitus. N Eng J Med. 1995; 332(18):1210–7. https://doi.org/10.1056/NEJM199505043321807. PMid:7700316 DOI: https://doi.org/10.1056/NEJM199505043321807
Arner S, Meyerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain. 1988; 33(1):11–23. https://doi.org/10.1016/0304-3959(88)90198-4 DOI: https://doi.org/10.1016/0304-3959(88)90198-4
Abuaisha BB, Costanzi JB, Boulton AJ. Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study. Diabetes Res Clin Pract. 1998; 39(2):115–21. https://doi.org/10.1016/S0168-8227(97)00123-X DOI: https://doi.org/10.1016/S0168-8227(97)00123-X
Apfel SC. Introduction to diabetic neuropathy. Am J Med. 1999; 107(2):1S. https://doi.org/10.1016/S0002-9343(99)00006-6 DOI: https://doi.org/10.1016/S0002-9343(99)00006-6
Baynes JW, Thorpe R. Role of oxidative stress in diabetic complications. A new perspective on an old paradigm. Diabetes. 1999; 48:1–9. https://doi.org/10.2337/diabetes.48.1.1. PMid:9892215 DOI: https://doi.org/10.2337/diabetes.48.1.1
Kandhare AD, Raygude KS, Ghosh P. Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy. Fitoterapia 2012; 83:650–9. https://doi.org/10.1016/j.fitote.2012.01.010. PMid:22343014 DOI: https://doi.org/10.1016/j.fitote.2012.01.010
Schmelzer C, Lindner I, Rimbach G, Niklowitz P, Menke T, Döring F. Functions of coenzyme Q10 in inflammation and gene expression. Biofactors. 2008; 32(1–4):179–83. https://doi.org/10.1002/biof.5520320121. PMid:19096114 DOI: https://doi.org/10.1002/biof.5520320121
Kohli Y, Suto Y, Kodama T. Effect of hypoxia on acetic acid ulcer of the stomach in rats with or without coenzyme Q10. Jpn J Exp Med. 1981; 51:105–8. PMid:7277789.
Lenaz G, Fato R, Formiggini G, Genova ML. The role of Coenzyme Q in mitochondrial electron transport. Mitochondrion. 2007; 7:S8–33. https://doi.org/10.1016/j.mito.2007.03.009. PMid:17485246 DOI: https://doi.org/10.1016/j.mito.2007.03.009
Alhaider AA, Korashy HM, Sayed-Ahmed MM, Mobark M, Kfoury H, Mansour MA. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression. Chem Biol Interact. 2011; 192(3):233–42. https://doi.org/10.1016/j.cbi.2011.03.014. PMid:21457706 DOI: https://doi.org/10.1016/j.cbi.2011.03.014
Ma J, Yu H, Liu J, Chen Y, Wang Q, Xiang L. Metformin attenuates hyperalgesia and allodynia in rats with painful diabetic neuropathy induced by streptozotocin. Eur J Pharmacol. 2015; 764:599– 606. https://doi.org/10.1016/j.ejphar.2015.06.010. PMid:26054810 DOI: https://doi.org/10.1016/j.ejphar.2015.06.010
Maheshwari RA, Khatri K, Sailor GU, Balaraman R. Antidiabetic activity of Dibolin (a polyherbal formulation) in streptozotocin-nicotinamide induced type 2 diabetic rats. Int J Pharm Pharm Sci. 2014; 2:893–7.
Garjani A, Andalib S, Biabani S. Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat. Eur J Pharmacol. 2011; 666(1–3):135–41. https://doi.org/10.1016/j.ejphar.2011.04.061. PMid:21570962 DOI: https://doi.org/10.1016/j.ejphar.2011.04.061
Waisundara VY, Hsu A, Tan BK, Huang D. Baicalin reduces mitochondrial damage in streptozotocininduced diabetic Wistar rats. Diabetes Metab Res Rev. 2009; 25(7):671–7. https://doi.org/10.1002/dmrr.1005. PMid:19688721 DOI: https://doi.org/10.1002/dmrr.1005
Sharma AK, Sharma A, Kumari R, Kishore K, Sharma D, Srinivasan BP, et al. Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats. J Biomed Res. 2012; 26(3):200–10. https://doi.org/10.7555/JBR.26.20110054. PMid:23554750. PMCid:PMC3596070 DOI: https://doi.org/10.7555/JBR.26.20110054
Woolfe G, MacDonald AD. The evaluation of the analgesic action of pethidine hydrochloride (Demerol). J Pharmacol Exp Ther. 1944; 80:300–7.
Sharma SS, Kumar A, Kaundal R. 4-Amino 1,8-napthalimide: A potent PARP inhibitor, its neuroprotective role in experimental diabetic neuropathy. Life Sci. 2008; 82:570–6. https://doi.org/10.1016/j.lfs.2007.11.031. PMid:18262571 DOI: https://doi.org/10.1016/j.lfs.2007.11.031
Slater TF, Sawyer BC. The stimulatory effect of carbon tetrachloride and other halogenalkane or peroxidative reaction in the rat liver functions in vitro. Biochem J. 1971; 123(5):805–15. https://doi.org/10.1042/bj1230805. PMid:4399399. PMCid:PMC1177080 DOI: https://doi.org/10.1042/bj1230805
Mishra HP, Fridovich I. The role of superoxide anion in the autooxidation of epinephrine and a simple assay of superoxide dismutase. J Biol Chem. 1972; 247(10):3170–5. https://doi.org/10.1016/S0021-9258(19)45228-9 DOI: https://doi.org/10.1016/S0021-9258(19)45228-9
Moron MS, Depierre JW. Levels of glutathione, glutathione reductase and glutathione S transferase activities in rat lung and liver. Biochim Biophys Acta. 1999; 582(1):67–78. https://doi.org/10.1016/0304-4165(79)90289-7 DOI: https://doi.org/10.1016/0304-4165(79)90289-7
Maheshwari R, Pandya B, Balaraman R, Seth AK, Yadav YC, Sankar VS. Hepatoprotective effect of Livplus-A polyherbal formulation. Pharmacogn J. 2015; 7(5):311–6. https://doi.org/10.5530/pj.2015.5.11 DOI: https://doi.org/10.5530/pj.2015.5.11
Kumar A, Kaundal RK, Iyer S, Sharma SS. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sci. 2007; 80(13):1236–44. https://doi.org/10.1016/j.lfs.2006.12.036. PMid:17289084 DOI: https://doi.org/10.1016/j.lfs.2006.12.036
Stevens MJ, Obrosova I, Cao X, Van Huysen C, Greene DA. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes. 2000; 49(6):1006–15. https://doi.org/10.2337/diabetes.49.6.1006. PMid:10866054 DOI: https://doi.org/10.2337/diabetes.49.6.1006
Sayyed SG, Kumar A, Sharma SS. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy. Life Sci. 2006; 79:777–83. https://doi.org/10.1016/j.lfs.2006.02.033. PMid:16581090 DOI: https://doi.org/10.1016/j.lfs.2006.02.033
Cui XP, Li BY, Gao HQ, Wei N, Wang WL, Lu M. Effects of grape seed proanthocyanidin extracts on peripheral nerves in streptozocin-induced diabetic rats. Nutr Sci Vitaminol. 2008; 54(4):321–8. https://doi.org/10.3177/jnsv.54.321. PMid:18797155 DOI: https://doi.org/10.3177/jnsv.54.321
Arora M, Kumar A, Kaundal RK, Sharma SS. Amelioration of neurological and biochemical deficits by peroxynitrite decomposition catalysts in experimental diabetic neuropathy. Eur J Pharmacol. 2008; 596(1–3):77–83. https://doi.org/10.1016/j.ejphar.2008.08.003. PMid:18768138 DOI: https://doi.org/10.1016/j.ejphar.2008.08.003
Saini AK, Kumar HAS, Sharma SS. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy. Eur J Pharmacol. 2007; 568:164–72. https://doi.org/10.1016/j.ejphar.2007.04.016. PMid:17521626 DOI: https://doi.org/10.1016/j.ejphar.2007.04.016